A New End-To-End CDMO Takes Shape: What Does Adare’s Acquisition of Frontida Mean for the Industry?
With the acquisition of Frontida, Adare Pharma Solutions has taken a major step toward becoming a fully integrated, end-to-end CDMO. In this interview, Tom Sellig explains how the expanded global footprint, enhanced capabilities, and increased agility are helping Adare better support customers from early development through commercialization.
Click "download" or "view" below to access this resource.
